While women’s genetic makeup makes them more prone to autoimmune diseases, are there other factors contributing to the ...

"IO Biotech enrols all subjects in Phase II trial of cancer combination therapy" was originally created and published by ...

(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

Cancer is a multifactorial disease that affects millions of individuals worldwide and has a profound impact on public health. The heterogeneity of solid ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Dermatomyositis is a chronic autoimmune disease characterised by muscle weakness, skin lesions, and systemic complications.

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

MaaT Pharma has seen its microbiome therapy for patients living with treatment-induced dysbiosis hit its endpoints.

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

A small study of 18 patients with skin cancer found that the combination of vitamin D and chemotherapy provided an immune ...